Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines
  2. Gil, C.; Climent, N.; Garcia, F.; Hurtado, C.; Nieto-Marquez, S.; Leon, A.; Garcia, M. T.; Rovira, C.; Miralles, L.; Dalmau, J.; Pumarola, T.; Almela, M.; Martinez-Picado, J.; Lifson, J. D.; Zamora, L.; Miro, J. M.; Brander, C.; Clotet, B.; Gallart, T.; Gatell, J. M.
  3. Vaccine. 2011, Aug; 29(34): 5711-5724.
  1. 2.   Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy
  2. Joshi, A.; Garg, H.; Ablan, S.; Freed, E. O.; Nagashima, K.; Manjunath, N.; Shankar, P.
  3. Virology. 2011, Jul; 415(2): 95-106.
  1. 3.   Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
  2. Chen, L.; Kwon, Y. D.; Zhou, T. Q.; Wu, X. L.; O'Dell, S.; Cavacini, L.; Hessell, A. J.; Pancera, M.; Tang, M.; Xu, L.; Yang, Z. Y.; Zhang, M. Y.; Arthos, J.; Burton, D. R.; Dimitrov, D. S.; Nabel, G. J.; Posner, M. R.; Sodroski, J.; Wyatt, R.
  3. Science. 2009 326(5956): 1123-1127.
  1. 4.   Evidence that Productive Human Immunodeficiency Virus Type 1 Assembly Can Occur in an Intracellular Compartment
  2. Joshi, A.; Ablan, S. D.; Soheilian, F.; Nagashima, K.; Freed, E. O.
  3. Journal of Virology. 2009 83(11): 5375-5387.
  1. 5.   HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF(165)
  2. Lambert, S.; Bouttier, M.; Vassy, R.; Seigneuret, M.; Petrow-Sadowski, C.; Janvier, S.; Heveker, N.; Ruscetti, F. W.; Perret, G.; Jones, K. S.; Pique, C.
  3. Blood. 2009 113(21): 5176-5185.
  1. 6.   Efficiency of human immunodeficiency virus type 1 postentry infection processes: Evidence against disproportionate numbers of defective virions
  2. Thomas, J. A.; Ott, D. E.; Gorelick, R. J.
  3. Journal of Virology. 2007, Apr; 81(8): 4367-4370.
  1. 7.   Gag-specific CD8(+) T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression
  2. Sacha, J. B.; Chung, C.; Rakasz, E. G.; Spencer, S. P.; Jonas, A. K.; Bean, A. T.; Lee, W.; Burwitz, B. J.; Stephany, J. J.; Loffredo, J. T.; Allison, D. B.; Adnan, S.; Hoji, A.; Wilson, N. A.; Friedrich, T. C.; Lifson, J. D.; Yang, O. O.; Watkins, D. I.
  3. Journal of Immunology. 2007, Mar; 178(5): 2746-2754.
  1. 8.   Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells
  2. Jones, K. S.; Fugo, K.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D. C.; Lisinski, I.; Cushman, S. W.; Jacobson, S.; Ruscetti, F. W.
  3. Journal of Virology. 2006, Sep; 80(17): 8291-8302.
  1. 9.   Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor
  2. Kuhn, J. H.; Radoshitzky, S. R.; Guth, A. C.; Warfield, K. L.; Li, W. H.; Vincent, M. J.; Towner, J. S.; Nichol, S. T.; Bavari, S.; Choe, H.; Aman, M. J.; Farzan, M.
  3. Journal of Biological Chemistry. 2006, Jun; 281(23): 15951-15958.
  1. 10.   Innate immune dysfunction in HIV infection: Effect of HIV envelope-NK cell interactions
  2. Kottilil, S.; Shin, K.; Jackson, J. O.; Reitano, K. N.; O'Shea, M. A.; Yang, J.; Hallahan, C. W.; Lempicki, R.; Arthos, J.; Fauci, A. S.
  3. Journal of Immunology. 2006, JAN 15; 176(2): 1107-1114.
  1. 11.   Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies
  2. Zhu, Z. Y.; Dimitrov, A. S.; Bossart, K. N.; Crameri, G.; Bishop, K. A.; Choudhry, V.; Mungall, B. A.; Feng, Y. R.; Choudhary, A.; Zhang, M. Y.; Feng, Y.; Wang, L. F.; Xiao, X. D.; Eaton, B. T.; Broder, C. C.; Dimitrov, D. S.
  3. Journal of Virology. 2006, JAN; 80(2): 891-899.
  1. 12.   Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIV(mac)239
  2. Evans, D. T.; Bricker, J. E.; Sanford, H. B.; Lang, S.; Carville, A.; Richardson, B. A.; Piatak, M.; Lifson, J. D.; Mansfield, K. G.; Desrosiers, R. C.
  3. Journal of Virology. 2005, JUN; 79(12): 7707-7720.
  1. 13.   Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins
  2. Morcock, D. R.; Thomas, J. A.; Gagliardi, T. D.; Gorelick, R. J.; Roser, J. D.; Chertova, E. N.; Bess, J. W.; Ott, D. E.; Sattentau, Q. J.; Frank, I.; Pope, M.; Lifson, J. D.; Henderson, L. E.; Crise, B. J.
  3. Journal of Virology. 2005, FEB; 79(3): 1533-1542.
  1. 14.   Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain
  2. Xiao, X. D.; Feng, Y.; Chakraborti, S.; Dimitrov, D. S.
  3. Biochemical and Biophysical Research Communications. 2004, SEP 10; 322(1): 93-99.
  1. 15.   Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning
  2. Zhang, M. Y.; Shu, Y. U.; Rudolph, D.; Prabakaran, P.; Labrijn, A. F.; Zwick, M. B.; Lal, R. B.; Dimitrov, D. S.
  3. Journal of Molecular Biology. 2004 335(1): 209-219.
  1. 16.   Probing protein-carbohydrate interactions with microarrays of synthetic oligosaccharides
  2. Ratner, D. M.; Adams, E. W.; Su, J.; O'Keefe, B. R.; Mrksich, M.; Seeberger, P. H.
  3. Chembiochem. 2004 5(3): 379-382.
  1. 17.   Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion
  2. Rawat, S. S.; Eaton, J.; Gallo, S. A.; Martin, T. D.; Ablan, S.; Ratnayake, S.; Viard, M.; KewalRamani, V. N.; Wang, J. M.; Blumenthal, R.; Puri, A.
  3. Virology. 2004 318(1): 55-65.
  1. 18.   Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades
  2. Zhang, M. Y.; Shu, Y.; Sidorov, I.; Dimitrov, D. S.
  3. Antiviral Research. 2004 61(3): 161-164.
  1. 19.   Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo
  2. Fitzgerald, W.; Sylwester, A. W.; Grivel, J. C.; Lifson, J. D.; Margolis, L. B.
  3. Journal of Virology. 2004 78(13): 7061-7068.
  1. 20.   Determinants of increased replicative capacity of serially passaged simian immunodeficiency virus with nef deleted in rhesus monkeys
  2. Alexander, L.; Illyinskii, P. O.; Lang, S. M.; Means, R. E.; Lifson, J.; Mansfield, K.; Desrosiers, R. C.
  3. Journal of Virology. 2003 77(12): 6823-6835.
  1. 21.   Selective interactions of the human immunodeficiency virus- inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins
  2. Shenoy, S. R.; O'Keefe, B. R.; Bolmstedt, A. J.; Cartner, L. K.; Boyd, M. R.
  3. Journal of Pharmacology and Experimental Therapeutics. 2001 297(2): 704-710.
  1. 22.   Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5
  2. Hug, P.; Lin, H. M. J.; Korte, T.; Xiao, X. D.; Dimitrov, D. S.; Wang, J. M.; Puri, A.; Blumenthal, R.
  3. Journal of Virology. 2000 74(14): 6377-6385.
  1. 23.   Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 co-receptor and ligand binding function
  2. Howard, O. M. Z.; Shirakawa, A. K.; Turpin, J. A.; Maynard, A.; Tobin, G. J.; Carrington, M.; Oppenheim, J. J.; Dean, M.
  3. Journal of Biological Chemistry. 1999 274(23): 16228-16234.
  1. 24.   Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen
  2. Polacino, P.; Stallard, V.; Klaniecki, J. E.; Montefiori, D. C.; Langlois, A. J.; Richardson, B. A.; Overbaugh, J.; Morton, W. R.; Benveniste, R. E.; Hu, S. L.
  3. Journal of Virology. 1999 73(1): 618-630.
  1. 25.   Role of glycosphingolipids in HIV-1 entry: requirement of globotriosylceramide (Gb3) in CD4/CXCR4-dependent fusion
  2. Puri, A.; Hug, P.; Jernigan, K.; Rose, P.; Blumenthal, R.
  3. Bioscience Reports. 1999 19(4): 317-325.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel